ANI Pharmaceuticals, Inc. (ANIP) — Stock Score Summary

ANI Pharmaceuticals, Inc. (ANIP) has a MoatMap StockRank of 96/100 based on Quality (69/100), Value (52/100), and Momentum (67/100) factor scores. The current signal is STRONG BUY. ANI Pharmaceuticals is a US generic and branded drug manufacturer. It lacks the proprietary manufacturing moat of a high-end CDMO and is vulnerable to generic price erosion and high input costs.

ANI Pharmaceuticals focuses on developing, manufacturing, and marketing branded and generic prescription medicines, particularly those with complex formulations or specialized manufacturing requirements. The company specializes in niche and limited-source generic products, often acquiring and revitalizing neglected drugs, which can face fewer competitors. ANI Pharmaceuticals is a specialty pharmaceutical firm emphasizing unique or underserved drug markets, leveraging its capabilities in regulatory navigation and complex drug manufacturing.

Key Financial Metrics

Price$81.31
Market Cap$1.8B
P/E (TTM)20.26
P/E (Forward)7.46
Price/Book3.01
Return on Equity18.3%
Return on Invested Capital10.0%
Debt/Equity112.08
Gross Margin60.8%
Operating Margin16.3%
Revenue Growth20.5%
Free Cash Flow$140M

ANI Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is ANI Pharmaceuticals, Inc.’s (ANIP) StockRank?
MoatMap’s StockRank for ANI Pharmaceuticals, Inc. (ANIP) is 96/100, with a Strong Buy signal. It is a composite of Quality (69), Value (52), and Momentum (67) factor ranks across MoatMap’s 19,000+ stock universe.
Does ANI Pharmaceuticals, Inc. have an economic moat?
ANI Pharmaceuticals, Inc. (ANIP) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ANI Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for ANI Pharmaceuticals, Inc. (ANIP) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ANI Pharmaceuticals, Inc. in?
ANI Pharmaceuticals, Inc. (ANIP) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksANIP deep dive reportAI ChampionsHow we score stocksSense-check another stock